Clinical characteristics of 17 patients with COVID-19 and systemic autoimmune diseases: a retrospective study.

Yao HuangZhe ChenYu WangLiang HanKai QinWenya HuangYing HuangHui WangPan ShenXin BaWeiji LinHui DongMingmin ZhangSheng-Hao Tu

Published in: Annals of the rheumatic diseases (2020)

Older males with chronic comorbidities are more vulnerable to severe COVID-19. The lower proportion of COVID-19 in patients with systemic AIDs needs more high-quality human clinical trials and in-depth mechanism researches. Of note, the withdrawal of anti-AIDs treatments during hospitalisation can lead to flares of diseases.

Keyphrases

coronavirus disease
sars cov
clinical trial
endothelial cells
antiretroviral therapy
drug induced
respiratory syndrome coronavirus
early onset
physical activity
community dwelling
induced pluripotent stem cells
middle aged